Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis. (Q47745198)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis. |
scientific article |
Statements
1 reference
Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis. (English)
1 reference
Alice B Gottlieb
1 reference
Sewon Kang
1 reference
Kenneth G Linden
1 reference
Mark Lebwohl
1 reference
Alan Menter
1 reference
Ahsan A Abdulghani
1 reference
Michael Goldfarb
1 reference
Nicole Chieffo
1 reference
Mark C Totoritis
1 reference
1 April 2004
1 reference
1 reference
111
1 reference
1
1 reference
28-37
1 reference
Identifiers
1 reference
1 reference